Impact of Early Age at Menopause on Disease Outcomes in Postmenopausal Women with Rheumatoid Arthritis: a Large Observational Cohort Study of Korean Patients with Rheumatoid Arthritis

Overview

Journal RMD Open

Publisher BMJ Publishing Group

Specialty Rheumatology

Date 2023 Feb 15

PMID 36792311

Authors

Eun Hye Park

Eun Ha Kang

Yun Jong Lee

You-Jung Ha

Affiliations

Soon will be listed here.

Abstract

Objectives: To assess the differences in clinical outcomes between patients with rheumatoid arthritis (RA) with early menopause (EM) (<45 years) and usual menopause (UM) (≥45 years) and to identify the impact of EM on longitudinal changes in RA activity and patient-reported outcomes (PROs).

Methods: We recruited 2878 postmenopausal women with RA from the Korean Observational Study Network for Arthritis. Patients were examined at baseline and for 5 consecutive years using the Simplified Disease Activity Index (SDAI), Health Assessment Questionnaire-Disability Index (HAQ-DI) and other PROs. Generalised estimating equation (GEE) analyses were performed among patients with a baseline SDAI of >11 to evaluate the impact of EM on longitudinal changes in RA activity and PROs.

Results: The EM group (n=437) was younger than the UM group (n=2441), but the RA duration was similar between the two groups. The EM group was more educated and more likely to be seronegative at enrolment. Moreover, the EM group demonstrated higher disease activity and worse PROs for global assessment, fatigue, sleep disturbance and health-related quality of life (HRQoL) (all p<0.05) at baseline. The GEE model revealed that EM significantly influenced the rate of SDAI change (β=1.265, p=0.004) after adjusting for age, RA duration, biologics use and SDAI at baseline. The EM group was also significantly associated with increased HAQ-DI scores and decreased EQ-5D-utility values during the 5-year follow-up period.

Conclusion: Patients with RA and EM demonstrate higher disease activity and poorer HRQoL. Furthermore, EM significantly affects the longitudinal changes in disease activity and PROs in patients with RA.

Citing Articles

How is age at menopause and reproductive lifespan associated with chronic pain outcomes in postmenopausal women?.

Lund C, Rosseland L, Steingrimsdottir O, Engdahl B, Stubhaug A, Furberg A Pain. 2024; 166(1):144-152.

PMID: 39058956 PMC: 11647823. DOI: 10.1097/j.pain.0000000000003333.

Hormonal and reproductive factors in relation to the risk of rheumatoid arthritis in women: a prospective cohort study with 223 526 participants.

Jiang L, Zhang R, Musonye H, Zhao H, He Y, Zhao C RMD Open. 2024; 10(1).

PMID: 38195516 PMC: 10826586. DOI: 10.1136/rmdopen-2023-003338.

Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry.

Jung J, Lee E, Kim J, Suh C, Shin K, Kim J Arthritis Res Ther. 2023; 25(1):174.

PMID: 37726808 PMC: 10507947. DOI: 10.1186/s13075-023-03165-w.

Complex role of oestrogens in the risk and severity of rheumatoid arthritis in menopause.

Cutolo M, Gotelli E RMD Open. 2023; 9(2).

PMID: 37321667 PMC: 10277547. DOI: 10.1136/rmdopen-2023-003176.

References

Merlino L, Cerhan J, Criswell L, Mikuls T, Saag K . Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women. Semin Arthritis Rheum. 2003; 33(2):72-82. DOI: 10.1016/s0049-0172(03)00084-2. View

Gallagher J . Effect of early menopause on bone mineral density and fractures. Menopause. 2007; 14(3 Pt 2):567-71. DOI: 10.1097/gme.0b013e31804c793d. View

Pikwer M, Bergstrom U, Nilsson J, Jacobsson L, Berglund G, Turesson C . Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis. 2008; 68(4):526-30. DOI: 10.1136/ard.2007.084707. View

Faubion S, Kuhle C, Shuster L, Rocca W . Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015; 18(4):483-91. PMC: 4581591. DOI: 10.3109/13697137.2015.1020484. View

Eun Y, Jeon K, Han K, Kim D, Kim H, Lee J . Menopausal factors and risk of seropositive rheumatoid arthritis in postmenopausal women: a nationwide cohort study of 1.36 million women. Sci Rep. 2020; 10(1):20793. PMC: 7695821. DOI: 10.1038/s41598-020-77841-1. View

Kaczmarek M . The timing of natural menopause in Poland and associated factors. Maturitas. 2007; 57(2):139-53. DOI: 10.1016/j.maturitas.2006.12.001. View

Felson D . Defining remission in rheumatoid arthritis. Ann Rheum Dis. 2012; 71 Suppl 2:i86-8. PMC: 3648878. DOI: 10.1136/annrheumdis-2011-200618. View

van der Voort D, van Der Weijer P, Barentsen R . Early menopause: increased fracture risk at older age. Osteoporos Int. 2003; 14(6):525-30. DOI: 10.1007/s00198-003-1408-1. View

Sung Y, Cho S, Choi C, Park S, Shim J, Ahn J . Korean Observational Study Network for Arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea. Semin Arthritis Rheum. 2011; 41(6):745-51. DOI: 10.1016/j.semarthrit.2011.09.007. View

10.

Gold E, Bromberger J, Crawford S, Samuels S, Greendale G, Harlow S . Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol. 2001; 153(9):865-74. DOI: 10.1093/aje/153.9.865. View

11.

Kuiper S, van Gestel A, Swinkels H, de Boo T, Da Silva J, van Riel P . Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol. 2001; 28(8):1809-16. View

12.

Smolen J, Landewe R, Bijlsma J, Burmester G, Dougados M, Kerschbaumer A . EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020; 79(6):685-699. DOI: 10.1136/annrheumdis-2019-216655. View

13.

Hall G, Daniels M, Huskisson E, Spector T . A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis. 1994; 53(2):112-6. PMC: 1005262. DOI: 10.1136/ard.53.2.112. View

14.

Langton C, Whitcomb B, Purdue-Smithe A, Sievert L, Hankinson S, Manson J . Association of Parity and Breastfeeding With Risk of Early Natural Menopause. JAMA Netw Open. 2020; 3(1):e1919615. PMC: 6991272. DOI: 10.1001/jamanetworkopen.2019.19615. View

15.

ORourke M, Nichols W . Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension. 2005; 45(4):652-8. DOI: 10.1161/01.HYP.0000153793.84859.b8. View

16.

Crowson C, Matteson E, Myasoedova E, Michet C, Ernste F, Warrington K . The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011; 63(3):633-9. PMC: 3078757. DOI: 10.1002/art.30155. View

17.

Katchamart W, Johnson S, Lin H, Phumethum V, Salliot C, Bombardier C . Predictors for remission in rheumatoid arthritis patients: A systematic review. Arthritis Care Res (Hoboken). 2010; 62(8):1128-43. DOI: 10.1002/acr.20188. View

18.

Gold E . The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am. 2011; 38(3):425-40. PMC: 3285482. DOI: 10.1016/j.ogc.2011.05.002. View

19.

Pikwer M, Nilsson J, Bergstrom U, Jacobsson L, Turesson C . Early menopause and severity of rheumatoid arthritis in women older than 45 years. Arthritis Res Ther. 2012; 14(4):R190. PMC: 3580586. DOI: 10.1186/ar4021. View

20.

Burger H, Hale G, Robertson D, Dennerstein L . A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update. 2007; 13(6):559-65. DOI: 10.1093/humupd/dmm020. View